Ajax-Loading

Johnson & Johnson - Price To Sales Ratio

Johnson & Johnson's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 4.62 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Johnson & Johnson's third quarter, the item "Price To Sales Ratio" stands at 4.62. This represents an increase of 15.90 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.73 percent compared to the value the year prior.
The 1 year change in percent is 8.73.
The 3 year change in percent is 22.59.

The Serie's long term average value is 4.06. It's latest available value, on 09/30/2025, is 13.97 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is +26.96%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Price To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Sales Ratio905,699,262,464.00
LogoAbbVie Inc - Price To Sales Ratio399,570,305,024.00
LogoRoche Holding AG - Price To Sales Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price To Sales Ratio280,205,508,085.11
LogoNovartis AG - Price To Sales Ratio255,096,620,580.91